Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haesook Kim

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Cancer|August 27, 2004
A Phase II trial of gemcitabine for metastatic neuroendocrine tumorsMatthew H Kulke, Haesook Kim, Jeffrey W Clark, et al.
Cancer|July 13, 2002
A phase II trial of gemcitabine in patients with advanced hepatocellular carcinomaCharles S Fuchs, Jeffrey W Clark, David P Ryan, et al.
Leukemia Research|September 26, 2006
Utility of interphase FISH to stratify patients into cytogenetic risk categories at diagnosis of AML in an Eastern Cooperative Oncology Group (ECOG) clinical trial (E1900)Gail H Vance, Haesook Kim, Gary A Hicks, et al.
Medicine|December 20, 2019
Beta wave enhancement neurofeedback improves cognitive functions in patients with mild cognitive impairment: A preliminary pilot studyJung-Hee Jang, Jieun Kim, Gunhyuk Park, et al.
Haematologica|January 19, 2019
A confirmation of chronic graft-<i>versus</i>-host disease prediction using allogeneic HY antibodies following sex-mismatched hematopoietic cell transplantationJed Paul, Hideki Nakasone, Bita Sahaf, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 4, 2016
An Open-Label Phase II Randomized Trial of Topical Dexamethasone and Tacrolimus Solutions for the Treatment of Oral Chronic Graft-versus-Host DiseaseNathaniel Treister, Shuli Li, Haesook Kim, et al.
Blood|April 29, 2006
IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivoEmmanuel Zorn, Erik A Nelson, Mehrdad Mohseni, et al.
Pediatric Blood & Cancer|September 11, 2009
Treatment of children with acute promyelocytic leukemia: results of the first North American Intergroup trial INT0129John Gregory, Haesook Kim, Todd Alonzo, et al.
Cancer Journal (Sudbury, Mass.)|November 6, 2002
A phase II study of troglitazone, an activator of the PPARgamma receptor, in patients with chemotherapy-resistant metastatic colorectal cancerMatthew H Kulke, George D Demetri, Norman E Sharpless, et al.
Digestive Diseases and Sciences|January 18, 2006
A phase II trial of irinotecan in patients with previously untreated advanced esophageal and gastric adenocarcinomaPeter C Enzinger, Matthew H Kulke, Jeffrey W Clark, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Cancer|August 27, 2004
A Phase II trial of gemcitabine for metastatic neuroendocrine tumorsMatthew H Kulke, Haesook Kim, Jeffrey W Clark, et al.
Cancer|July 13, 2002
A phase II trial of gemcitabine in patients with advanced hepatocellular carcinomaCharles S Fuchs, Jeffrey W Clark, David P Ryan, et al.
Leukemia Research|September 26, 2006
Utility of interphase FISH to stratify patients into cytogenetic risk categories at diagnosis of AML in an Eastern Cooperative Oncology Group (ECOG) clinical trial (E1900)Gail H Vance, Haesook Kim, Gary A Hicks, et al.
Medicine|December 20, 2019
Beta wave enhancement neurofeedback improves cognitive functions in patients with mild cognitive impairment: A preliminary pilot studyJung-Hee Jang, Jieun Kim, Gunhyuk Park, et al.
Haematologica|January 19, 2019
A confirmation of chronic graft-<i>versus</i>-host disease prediction using allogeneic HY antibodies following sex-mismatched hematopoietic cell transplantationJed Paul, Hideki Nakasone, Bita Sahaf, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 4, 2016
An Open-Label Phase II Randomized Trial of Topical Dexamethasone and Tacrolimus Solutions for the Treatment of Oral Chronic Graft-versus-Host DiseaseNathaniel Treister, Shuli Li, Haesook Kim, et al.
Blood|April 29, 2006
IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivoEmmanuel Zorn, Erik A Nelson, Mehrdad Mohseni, et al.
Pediatric Blood & Cancer|September 11, 2009
Treatment of children with acute promyelocytic leukemia: results of the first North American Intergroup trial INT0129John Gregory, Haesook Kim, Todd Alonzo, et al.
Cancer Journal (Sudbury, Mass.)|November 6, 2002
A phase II study of troglitazone, an activator of the PPARgamma receptor, in patients with chemotherapy-resistant metastatic colorectal cancerMatthew H Kulke, George D Demetri, Norman E Sharpless, et al.
Digestive Diseases and Sciences|January 18, 2006
A phase II trial of irinotecan in patients with previously untreated advanced esophageal and gastric adenocarcinomaPeter C Enzinger, Matthew H Kulke, Jeffrey W Clark, et al.
Pageof 4